Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial

about

Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial

Item

http://www.wikidata.org/entity/Q56379383

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Association of ERBB Mutations ...... ng 8 Randomized Clinical Trial

@en

Association of ERBB Mutations ...... ng 8 Randomized Clinical Trial

@nl

type

Item

label

Association of ERBB Mutations ...... ng 8 Randomized Clinical Trial

@en

Association of ERBB Mutations ...... ng 8 Randomized Clinical Trial

@nl

prefLabel

Association of ERBB Mutations ...... ng 8 Randomized Clinical Trial

@en

Association of ERBB Mutations ...... ng 8 Randomized Clinical Trial

@nl

P1476

Association of ERBB Mutations ...... ng 8 Randomized Clinical Trial

@en

P2093

Agnieszka Cseh

http://www.w3.org/2001/XMLSchema#string

Andrea Ardizzoni

http://www.w3.org/2001/XMLSchema#string

Andrea Fülöp

http://www.w3.org/2001/XMLSchema#string

Claudia Bühnemann

http://www.w3.org/2001/XMLSchema#string

Dolores Isla

http://www.w3.org/2001/XMLSchema#string

Enriqueta Felip

http://www.w3.org/2001/XMLSchema#string

Erdem Göker

http://www.w3.org/2001/XMLSchema#string

Eva Ehrnrooth

http://www.w3.org/2001/XMLSchema#string

Flavio Solca

http://www.w3.org/2001/XMLSchema#string

Glenwood D Goss

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenic ERBB3 mutations in human cancers

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Activating HER2 mutations in HER2 gene amplification negative breast cancer

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.

HER2 activating mutations are targets for colorectal cancer treatment

Comprehensive genomic characterization of squamous cell lung cancers.

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

Diverse somatic mutation patterns and pathway alterations in human cancers

P31

scholarly article

P356

10.1001/JAMAONCOL.2018.0775

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Alessandro Morabito

P577

2018-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29902295

http://www.w3.org/2001/XMLSchema#string

P932

6143014

http://www.w3.org/2001/XMLSchema#string